astemizole and tacrolimus

astemizole has been researched along with tacrolimus in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chase, P; Fallahi, M; Hodder, P; Karapetyan, YE; Lasmézas, CI; Ottenberg, G; Sferrazza, GF; Spicer, T; Weissmann, C; Zhou, M1

Other Studies

2 other study(ies) available for astemizole and tacrolimus

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Unique drug screening approach for prion diseases identifies tacrolimus and astemizole as antiprion agents.
    Proceedings of the National Academy of Sciences of the United States of America, 2013, Apr-23, Volume: 110, Issue:17

    Topics: Animals; Astemizole; Autophagy; Blotting, Western; Cell Line, Tumor; Drug Discovery; Drug Evaluation, Preclinical; Fluorescence Resonance Energy Transfer; High-Throughput Screening Assays; Humans; Kaplan-Meier Estimate; Mice; Mice, Inbred C57BL; Prion Diseases; Prions; Reverse Transcriptase Polymerase Chain Reaction; Tacrolimus

2013